Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder
申请人:Seo Eun Kyoung
公开号:US20120070515A1
公开(公告)日:2012-03-22
The present invention relates to a composition comprising an extract of
Anemarrhena asphodeloides
Bunge or the compounds isolated from the same, as an active ingredient. In particular, the extract and compounds have the excellent inhibitory effects on adipocyte differentiation, and thus can be used in a pharmaceutical composition and functional food for the prevention and treatment of lipid metabolism disorders.
Two newflavanone glycosides, alhagitin and alhagidin, have been isolated from the whole plant of Alhagi pseudalhagi and their structures established respectively as naringenin 5-methyl ether 4'-glucoside and hesperitin 7-galactosyl(1-->2)[rhamnosyl(1-->6)]glucoside by chemical and spectroscopic methods.
A new chalcone glycoside, together with pectolinarigenin, 7-hydroxyflavone and 7-hydroxyflavanone 7-O-glucoside have been isolated from the flowers and leaves of Clerodendron phlomidis. The structure of the chalcone glycoside has been established as 4,2',4'-trihydroxy-6'-methoxychalcone 4,4'-D-diglucoside by spectroscopic and degradative methods.